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We develop a sheep thoracic spine interbody fusion model to study the suitability of polycaprolactone-
based scaffold and recombinant human bone morphogenetic protein-2 (rhBMP-2) as a bone graft 
substitute within the thoracic spine. The surgical approach is a mini- open thoracotomy with relevance to 
minimally invasive deformity correction surgery for adolescent idiopathic scoliosis. To date there are no 
studies examining the use of this biodegradable implant in combination with biologics in a sheep thoracic 




In the present study, six sheep underwent a 3-level (T6/7, T8/9 and T10/11) discectomy with randomly 
allocated implantation of a different graft substitute at each of the three levels; (i) calcium phosphate 
(CaP) coated polycaprolactone-based scaffold plus 0.54μg rhBMP-2, (ii) CaP coated PCL- based scaffold 




Computed Tomographic scanning demonstrated higher fusion grades in the rhBMP-2 plus PCL- based 
scaffold group in comparison to either PCL-based scaffold alone or autograft. These results were 
supported by histological evaluations of the respective groups. Biomechanical testing revealed 
significantly higher stiffness for the rhBMP-2 plus PCL- based scaffold group in all loading directions in 




The results of this study demonstrate that rhBMP-2 plus PCL- based scaffold is a viable bone graft 





























Idiopathic scoliosis is a complex three-dimensional deformity affecting 2–3 % of the general population 
[1]. Recent efforts to improve surgical outcomes for scoliosis patients have focused on minimally 
invasive techniques to obtain curve correction without the need for an extensive surgical exposure, 
therefore reducing post-operative scarring. Several studies have demonstrated that the use of 
thoracoscopic approaches has minimized the surgical morbidity of open approaches, improved cosmesis 
and sagittal profile restoration and avoided many of the potential risks of a formal thoracotomy incision 
[2–6]. These thoracoscopic approaches involve discectomy and anterior interbody fusion. 
 
Bony fusion is essential for long-term stability in the instrumented spinal segment. Typically, this is 
achieved using autologous bone graft usually in the form of locally harvested rib (in the case of 
thoracoscopic spinal fusion). Autologous bone graft is still regarded as the gold standard for graft 
materials because it exhibits all three properties essential for adequate fusion; osteoconduction, 
osteoinduction and osteogenesis. 
 
Due to problems with donor site morbidity and autograft availability, recent spine fusion research has 
focused on the development of synthetic scaffolds in combination with growth factors such as 
recombinant human bone morphogenetic protein-2 (rhBMP-2) to achieve solid bony fusion following 
surgery without the need for autograft [7–9]. However, there is currently no large animal model for 
thoracic interbody fusion in which potential tissue engineering approaches with synthetic scaffolds can be 
assessed. 
 
The aim of this in vivo sheep study was to compare the performance of a bone graft substitute 
(comprising a bioactive resorbable scaffold in combination with rhBMP-2) with that of autograft as in the 




MATERIALS AND METHODS 
 
Bioresorbable polycaprolactone (PCL) scaffolds (2.5 x 9 x 15 mm3) were fabricated using biodegradable 
PCL and the Dual BioExtruder, a computer-controlled extrusion-based additive manufacturing device 
[10]. The semicircular shape of the scaffold was designed to conform to the cleared ovine thoracic 
anterior intervertebral disc space ensuring a low-profiled construct under compression as seen in Fig. 1a. 
The scaffold porosity of 60 % and a 90° lay down pattern offer a honeycomb architecture pattern 
conferring desirable physiological and mechanical properties [11]. 
 
Prior to implantation, a preliminary study was performed to assess the compressive strength of the 
scaffolds (refer to ‘‘Appendix’’). The scaffolds were coated with a biomimetic calcium phosphate (CaP) 
layer by immersion in concentrated simulated body fluid (10x) as previously described by Yang et al. 
which has been shown to promote bone ingrowth and regeneration [12]. The CaP coating was confirmed 
qualitatively by Alizarin red staining and scanning electron microscopy (SEM) of samples taken from 
batch-coated scaffolds as seen in Fig. 1b. The scaffolds functionalized with recombinant human bone 
morphogenetic protein-2 (rhBMP-2) were lyophilized with Baxter Tisseel_ fibrin sealant (Baxter AG, 
Austria) to act as a delivery system for the rhBMP-2 by creating a mesh-like structure within the scaffold 
pores to promote cellular activities. Fibrin sealant has the ability to temporarily contain osteoinductive 
material prior to implantation, yet release these materials in vivo over time while itself being completely 
absorbed [13]. A total of 180 µl was impregnated onto the sterile scaffold comprising 60 µg thrombin (in 
60µl sterile water) and 540 µg rhBMP-2 (in 60 µl sterile water). Commercially available rhBMP-2 
(Medtronic INFUSE® Sofamor Danek Memphis, USA) at a concentration of 9 µg/µl was used to 
functionalise the CaP coated scaffold at levels randomized to receive CaP scaffold plus rhBMP-2 (see 





Fig. 1. a. Bioresorbable PCL-scaffold fabricated using a computer controlled extrusion device (Dual BioExtruder). 
b. Representative scanning electron microscopy image at 100x magnification demonstrating homogenous biomimetic surface 
coating of calcium phosphate on individual scaffold strut filaments. c. Scaffold implanted into prepared intervertebral disc space 
after decortication and screw fixation. d. Post-operative X-ray (at 6-months postop) showing bone screw fixation across three-
levels as described in this study of ovine thoracic interbody fusion. 
 
All scientific work has been undertaken in accordance with the study protocol that has been approved by 
the Institute’s animal ethics committee. Six male Merino sheep aged 4–6 years and weighing 35–45 kg 
were operated on and survived to 6 months. The sheep underwent preliminary checks (visual xamination, 
weighing) upon arrival at the animal research facility prior to the intended date of surgery. Daily 
monitoring of the animals’ general condition, eating, drinking, defecation, urinating and gait was 
performed to ensure optimum health pre-operatively. Any sheep exhibiting signs of malaise, difficulty in 
feeding, impaired bladder or bowel functions or problems mobilizing were excluded from the study. 
 
Surgeries were performed under strict aseptic conditions. The sheep were anaesthetized with an 
intravenous induction of propofol (1 %) (4 mg/kg, IV) and maintained with 50 % oxygen in air, and 
isoflurane using a mechanical ventilator. The sheep were given buprenorphine (Temgesic®, 0.3 mg/ml) 
(0.005 mg/kg, IV) and ketorolac (Toradol®, 30 mg/ml) (0.5 mg/kg, SC) for pre-emptive and post-
operative bi-modal pain management. All the sheep received prophylactic [ciprofloxacin (200 mg/100 ml) 
(5 ml/kg, IV); cefazolin (Kefzol® 1 gram) (20 mg/kg, IV); gentamicin (80 mg/2 ml) (5 mg/kg IV)] and 
post-operative parenteral antibiotic regime. The animal’s heart rate, oxygen saturation and end-tidal 
carbon dioxide levels were monitored throughout the procedure. Following identification of disc levels of 
interest, the intervertebral discs were removed with ronguers and bone graft substitutes were inserted after 
disc space distraction. Interbody fusion was performed at three levels in each sheep (thoracic levels T6/7, 
T8/9 and T10/11). The graft type used at each treatment level in a particular animal was randomized to 
receive either (a) calcium phosphate (CaP) coated scaffold in combination with rhBMP-2 (b) CaP-coated 
scaffold alone or (c) autograft (mulched rib head). This way each sheep acted as its own internal control 
as performing different treatments at different spinal levels in the same animal has the advantage of 
providing the same biological environment for the different fusion constructs. Following implantation of 
these aforementioned interbody grafts, surgical stabilization of each treatment level was achieved by an 
assembly of two 25 mm multiaxial titanium vertebral body screws and a 5.5-mm titanium rod construct. 
Vertebral body screws and rods were obtained from Medtronic (CD Horizon® M8 titanium multiaxial 
screws, 5.5 mm rod). Intra-operatively, a temporary indwelling chest drain catheter was inserted to 
generate a negative pressure within the right thoracic cavity to ensure adequate lung re-expansion in the 
event of iatrogenic damage to the lung pleura and removed day-1 post-operatively. The sheep were 
transferred onto a custom-built hanging sling to support the animal in the immediate 24-h recovery 
period. Stock diet and tap water were made available to the animal ad libitum. The animal’s activity and 
wound condition were monitored on a daily basis. The sheep were closely monitored post-operatively for 
signs of pain (i.e. gait abnormalities/teeth gnawing/social isolation) by experienced animal handlers. All 
sheep were euthanized at 6 months. Spinal columns from T3 to L2 were dissected with retention of 
intersegmental ligamentous tissues and specimens stored at -20 °C until further evaluation. Fusion was 
assessed using three methods; high-resolution clinical Computed Tomography (CT), non-destructive 
biomechanical testing and histology, as described below. 
 
High- resolution clinical computed tomography 
Explanted thoracic spinal segments (T3–L2) of all the animals were radiographically assessed for fusion 
using axial and sagittal reconstructions of CT scans performed on a high-speed scanner (Phillips 
Brilliance 64) with the following parameters: X-ray source current and voltage of 200 mA and 120 kV, 
respectively, and a 14-cm field of view at 0.7 mm slice thickness. Reformatted sagittal images (left 
parasagittal, mid-sagittal and right parasagittal) were generated from the CT data using ImageJ software 
on a computer work station and fusion scores were assessed using the modified Sucato scale [14]. The 
percentage of disc fusion was calculated by dividing the osseous fusion area by the total discectomy area 
(as defined by the proximal and distal end plates and the posterior and anterior vertebral body margins for 





Fig. 2. CT reconstruction series demonstrating representative sagittal images of a 4 – point grading scale (modified 
Sucato) of each disc level; 0 points represent no fusion; 1 point, <50% fusion of the area of the disc space; 2 points, fusion 
between 50% and 75% of the area of the disc space; 3 points, fusion of more than 75% of the area of the disc space; and 4 points, 
complete fusion across the disc space. 
 
Non-destructive biomechanical testing 
Spines to be tested were thawed overnight in a 4°C refrigerator and covered with a polyethylene wrap to 
prevent dehydration. The three fusion levels (T6/7, T8/9 and T10/11) as well as uninstrumented levels 
above and below the fusion sites (T4/5 and T12/13, to provide baseline data) were carefully resected from 
the spines. Each excised level consisted of a cranial and caudal thoracic vertebra and intervertebral disc 
together with in situ stabilization vertebral body screws and rod. The fixation devices were removed prior 
to testing. The cranial and caudal vertebrae were potted in rigid polymethylmethacrylate (Palapress® 
Haraeus) and placed in a custom-made spine testing rig fitted onto an Instron MTS 8874 bi-axial testing 
machine which allowed for unconstrained horizontal plane movement during testing [15]. 
 
Three randomized treatment levels in each animal were biomechanically tested using the following 
protocol. As mentioned above, uninstrumented thoracic spine levels T4/5 and T12/13 were also tested to 
provide baseline normal stiffness values for comparison.  
 
Tests were performed in flexion/extension, right/left lateral bending and right/left axial rotation 
sequentially. For each test, loads of 2 Nm were applied under moment control in the positive and negative 
directions, respectively. This constituted one cycle, with each thoracic level undergoing five cycles for 
each of the three tests and the last cycle taken for analysis. The 2-Nm moment was chosen to allow non-
estructive testing of ovine thoracic motion segments [16]. Motion segment stiffness for each loading 
direction was calculated as the gradient of the regression line between applied moment and rotation fitted 
to data points. This region of the stress–strain curve represented the linear elastic region of the moment 
versus rotation curve, allowing accurate comparisons of stiffness between motion segments. 
 
Histology 
Following non-destructive mechanical testing, harvested spinal samples were fixed in 4 % 
paraformaldehyde in an opaque container (the volume of which was approximately ten times the 
specimen volume to achieve adequate fixation). Specimens were then dehydrated in a graded series of 
ethanols and embedded in acrylic resin (Technovit; Kulzer GmBH, Wehrheim, Germany) followed by 
longitudinal sectioning with a high-speed, water-cooled, precision saw (EXACT 300 CP Band System, 
Norderstedt, Germany) into parallel sections of 20 µm thickness. Sections were stained with Goldner’s 
trichrome to provide differentiation of connective tissues (e.g. bone, bone marrow, cartilage and fibrous 
tissue) as well as scaffold strut filaments. Histological evaluation was performed to compare the bone 
bridging process associated with each of the tested implant materials. New bone formation and 
remodelling were observed using a light inverted microscope (Olympus IX71). 
 
Statistical analysis 
Statistical analysis was performed to compare quantitative results between treatment groups. Since each 
animal acted as its own control, Wilcoxon signed rank sum tests were used to compare pairs of treatment 
groups (i.e. scaffold + rhBMP-2 versus scaffold alone, scaffold + rhBMP-2 versus autograft, scaffold 
alone versus autograft). Median stiffness values were calculated for each group from the biomechanical 
testing. Since the CT fusion grading system comprised only five discrete scores, mean rather than median 
values were calculated for each treatment group. A confidence level of 95 % was used to indicate 





High- resolution clinical computed tomography 
Results demonstrated overall higher grades of radiologically evident bony fusion in the rhBMP-2 plus 
PCL-based scaffold group in comparison with the scaffold alone as well as autograft as shown in Fig. 3. 
The mean CT fusion grade for rhBMP-2 plus PCL-based scaffold was 1.6, which was significantly higher 
than the mean grade for scaffold alone of 0.8 (P = 1 x 10-05). The mean CT fusion grade of the autograft 
group was 1.4, which was significantly higher than scaffold alone group (P = 0.017), but not significantly 
different from the scaffold plus rhBMP-2 group (P = 0.917). We also note that radiologically, there was 





Fig. 3. Bar chart representing mean CT fusion grades of the three implant graft groups (rhBMP-2 plus PCL-based 
scaffold, PCL-based scaffold alone and autograft. * indicates statistical significance (p < 0.05) 
Non- destructive biomechanical testing 
In all loading directions (flexion and extension, right and left lateral bending and left and right axial 
rotation), the rhBMP-2 plus scaffold group was significantly stiffer than either the scaffold alone (P = 2.5 
x 10-5) or the autograft group (P = 6.2 x 10-5). There was also a statistically significant difference between 
the median stiffness of the autograft and scaffold alone groups (P = 0.018). The median stiffness values 









Fig. 4. a. Representative range of motion graphs in axial rotation demonstrating differing stiffness of levels aforementioned; 
Normal thoracic spine level, rhBMP-2 plus PCL-based scaffold, autograft and PCL-based scaffold alone. b. Bar chart 






The histological evaluation shown in Fig. 5a indicates that in the rhBMP-2 plus PCL-based scaffold 
group, well aligned columns of mineralized bone formed in the struts of the scaffold filaments indicating 
a high degree of osseo-integration of the graft implant and, therefore, fusion. In the autograft group shown 
in Fig. 5b, there was histological evidence of mineralized bone and bone marrow formation indicating 
integration of the autograft bone implant and fusion as with the rhBMP-2 plus PCL-scaffold group. These 
observations are in agreement with those seen radiologically in that there were comparable CT fusion 
grades between autograft and rhBMP-2 plus PCL-based scaffold. There were areas of extensive PCL-
based scaffold strut graft resorption and evidence of osteoid formation in the PCL-based scaffold alone 




Fig. 5. a. Representative histological (longitudinal) sections with Goldner’s trichrome staining of specimen at 6-months post 
surgery from PCL- based scaffold plus rhBMP-2 group; b. autograft bone implant group; and c. PCLbased scaffold alone group. 
Histological evaluation shows; a. well- aligned columns of mineralized bone formed in the struts of the scaffold filaments in the 
PCL- based scaffold plus rhBMP-2 group.; b. evidence of mineralized bone and bone marrow indicating integration of autograft 
bone implant; c. areas of extensive scaffold strut resorption (arrows) and evidence of osteoid formation in the PCL-based scaffold 





This study assessed the biological performance of a biodegradable scaffold designed for bone tissue 
engineering in the thoracic spine using a mature ovine large animal model of thoracic interbody fusion. 
 
To date, there has not been a described model with the use of a bioresorbable scaffold in combination 
with growth factors in the setting of minimally invasive deformity correction of adolescent idiopathic 
scoliosis. The rhBMP-2 plus PCL-based scaffold demonstrated higher CT fusion grades as well as 
biomechanical stiffness in comparison to autograft. Results reported here demonstrate that PCL based 
scaffold functionalized with biologically active rhBMP-2 presents a suitable bone graft substitute to 
autograft in an ovine thoracic interbody fusion model. 
 
Bony fusion is essential for long-term stability of instrumented spinal segments in the setting of scoliosis 
deformity correction. Increasingly being studied are biologically active substances intended to extend, 
enhance or even replace autologous graft. Whilst autograft has widely been accepted as the gold standard 
for bone grafts, its use may be limited by availability as well as donor site morbidity. Since the discovery 
of BMP by Urist in 1951, the use of rhBMP-2 as an osteoinductive implant component has been on the 
increase because of its proven potency in vivo [17, 18]. Pseudoarthrosis or non-union is an undesirable 
outcome in spinal fusion surgery [18]. 
 
The effective use of rhBMP-2 within a scaffold allows for a user-defined dosage of this growth factor. It 
is noteworthy that the predefined dose of 0.54 µg rhBMP-2 used in this study was seen to be 
osteoinductive with no evidence of bone resorption in the rhBMP-2 plus PCL-based scaffold group—a 
problem seen with usage of higher than required doses of rhBMP-2 [19]. The overzealous use of BMP in 
hopes of promoting fusion can potentially lead to heterotopic bone formation which could result in 
symptomatic compression of the thecal sac or exiting nerve roots, calcification of the spinal cord or nerve 
roots, or unintended fusion of adjacent spinal segments [20]. The use of fibrin sealant to lyophilize BMP 
and control rate of diffusion acts to limit the potential risk of heterotopic bone formation as well as act a 
carrier agent for BMP [12]. 
 
The placement of different fusion constructs at the three levels is an approach used previously in spinal 
surgery literature [21]. Performing various treatments at different spinal levels within the same animal has 
the advantage of providing an identical biological environment for the different fusion constructs. In 
addition, the separation of treatment levels (by leaving an uninstrumented level between each treated 
level) minimizes the possibility of biomechanical or biochemical ‘crosstalk’ between treated levels (for 
example due to diffusion of BMP). Since three different fusion constructs are evaluated in one animal, 
paired statistical tests can be used to compare any two of the three constructs in the same animal, thus 
reducing the number of animals required to achieve statistical significance in the study. 
 
The role of the scaffold is to offer a structural support which promotes the repair and regeneration of 
tissues in combination with living cells and biologically active molecules. The scaffold material should be 
adequately robust to resist deformation upon cell infiltration as well as wound contraction forces in vivo. 
An internal fixation construct stabilizes the instrumented disc space and thus reduces the mechanical role 
of the scaffold in situ. This maintains sufficient structural integrity critical to a stable biomechanical 
environment for vascularization and bone remodeling. Bone formation is actively guided by BMP with 
subsequent cell colonization, migration, growth and differentiation. This forms the foundation of a viable 
tissue engineered construct (TEC) [22]. In addition, biomimetic properties of the calcium phosphate 
coating of the scaffolds actively promote bone regeneration. This has been concurrent with the findings of 
Abbah et al. in an analogous porcine lumbar interbody fusion model whereby complete bony fusion was 
seen as early as 3 months with advanced bone remodeling at 6 months [8]. We note that in the current 
study, the thoracic sternum as well as costochondral articulations provided additional support to the 
instrumented thoracic spine replicating the normal human thoracic spine surgical protocol [23]. 
 
The establishment of the surgical protocol in this study was crucial in ensuring a safe and reproducible 
ovine model of thoracic interbody fusion as described previously by Yong et al. [24]. Large animal spine 
surgery remains a technically demanding procedure with potentially severe consequences including 
neurological damage, respiratory distress and haemorrhage resulting in paralysis or even death if not 
meticulously carried out. The open mini-thoracotomy approach developed here allows the surgeon to 
visualize an adequate surgical field and also facilitates protection of the lung parietal pleura. Furthermore, 
the inferior vena cava and aorta can be visualized and protected thus preventing iatrogenic damage to the 
vessels which could result in severe haemorrhage. 
 
Previous large animal spine studies described the use of sheep as a suitable model given that sheep spines 
have been shown to exhibit similar kinematic behaviour, biomechanical response and analogous anatomy 
to the human spine [7,21]. In addition, the physical size of the sheep spine has been deemed sufficient to 
allow spinal surgery to be readily carried out and to allow for assessment of the success of the study using 
radiological, histological and biomechanical testing means [25]. 
 
There were several limitations to this study. The authors are aware that the results stated in this report 
represent that of a solitary time point (6 months) and, therefore, do not permit longitudinal comparisons 
nevertheless we intend to report on longer term follow-up in future. Another potential limitation to this 
study is the relatively small number of animals operated on. However, this number was seen to be 
consistent with other previous large animal spine studies [26]. A third potential limitation relates to the 
fusion grading system. Although a widely recognized previous fusion grading scale was utilized, CT axial 
resolution can compare poorly to the height of the thoracic disc space. Here we attempted to minimize 
this limitation with the use of high-resolution CT (0.7 mm slice spacing) and subsequent assessments by 
two independent reviewers in a blinded fashion. 
 
Whilst care must be taken in drawing inferences for paediatric deformity surgery, this large animal study 
provides pre-clinical evidence for the use of biodegradable scaffolds in combination with biologics in 
promoting bony fusion. It is envisaged that in addition to the specific implant configuration explored in 
this paper, the sheep thoracic spine fusion model used here could also form a platform for research into 







The results of this study demonstrate that rhBMP-2 plus PCL-based scaffold is a viable bone graft 
substitute to provide an optimal environment for bone fusion in a large animal model of thoracic spine 
interbody fusion. CT and biomechanically based fusion assessment of the synthetic PCL rhBMP-2 
construct indicated that it was statistically equivalent to (and slightly better than in terms of mean and 
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Compressive testing of the scaffolds demonstrated an initial alignment phase (up to 10 %) followed by 
elastic deformation with an elastic modulus of 9.1 ± 1.25 N/mm2. The scaffolds yielded at 25 ± 1 % 
strain and 117 ± 14 N (1.14 ± 0.13 MPa) after which permanent deformation progressively increases as 
the load increases as seen in Fig. 6. Macroscopic observation of compressed scaffolds revealed thinning 
of the construct by shearing between the deposited layers of material, while both the internal pore 
architecture and the overall scaffold shape and consistency were largely preserved. This observation is 
important as the preservation of the scaffolds’ overall shape once implanted surgically within the sheep’s 
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